These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10744747)

  • 1. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
    Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
    J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric phospholamban overexpression in transgenic mouse hearts.
    Chu G; Dorn GW; Luo W; Harrer JM; Kadambi VJ; Walsh RA; Kranias EG
    Circ Res; 1997 Oct; 81(4):485-92. PubMed ID: 9314829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
    Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
    J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility.
    Zvaritch E; Backx PH; Jirik F; Kimura Y; de Leon S; Schmidt AG; Hoit BD; Lester JW; Kranias EG; MacLennan DH
    J Biol Chem; 2000 May; 275(20):14985-91. PubMed ID: 10809743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
    Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.
    Haghighi K; Schmidt AG; Hoit BD; Brittsan AG; Yatani A; Lester JW; Zhai J; Kimura Y; Dorn GW; MacLennan DH; Kranias EG
    J Biol Chem; 2001 Jun; 276(26):24145-52. PubMed ID: 11328820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo.
    Chu G; Li L; Sato Y; Harrer JM; Kadambi VJ; Hoit BD; Bers DM; Kranias EG
    J Biol Chem; 1998 Dec; 273(50):33674-80. PubMed ID: 9837953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.
    Brittsan AG; Carr AN; Schmidt AG; Kranias EG
    J Biol Chem; 2000 Apr; 275(16):12129-35. PubMed ID: 10766848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
    Brittsan AG; Ginsburg KS; Chu G; Yatani A; Wolska BM; Schmidt AG; Asahi M; MacLennan DH; Bers DM; Kranias EG
    Circ Res; 2003 Apr; 92(7):769-76. PubMed ID: 12637367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.
    Zhao W; Frank KF; Chu G; Gerst MJ; Schmidt AG; Ji Y; Periasamy M; Kranias EG
    Cardiovasc Res; 2003 Jan; 57(1):71-81. PubMed ID: 12504816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart.
    Ver Heyen M; Heymans S; Antoons G; Reed T; Periasamy M; Awede B; Lebacq J; Vangheluwe P; Dewerchin M; Collen D; Sipido K; Carmeliet P; Wuytack F
    Circ Res; 2001 Oct; 89(9):838-46. PubMed ID: 11679415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.
    Chu G; Lester JW; Young KB; Luo W; Zhai J; Kranias EG
    J Biol Chem; 2000 Dec; 275(49):38938-43. PubMed ID: 10988285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility.
    He H; Meyer M; Martin JL; McDonough PM; Ho P; Lou X; Lew WY; Hilal-Dandan R; Dillmann WH
    Circulation; 1999 Aug; 100(9):974-80. PubMed ID: 10468529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport.
    Waggoner JR; Ginsburg KS; Mitton B; Haghighi K; Robbins J; Bers DM; Kranias EG
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H698-703. PubMed ID: 19112098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation.
    Autry JM; Jones LR
    J Biol Chem; 1997 Jun; 272(25):15872-80. PubMed ID: 9188486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure.
    Reddy LG; Autry JM; Jones LR; Thomas DD
    J Biol Chem; 1999 Mar; 274(12):7649-55. PubMed ID: 10075652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
    Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
    Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of phospholamban in the efficiency of cardiac sarcoplasmic reticulum Ca2+ transport.
    Frank K; Tilgmann C; Shannon TR; Bers DM; Kranias EG
    Biochemistry; 2000 Nov; 39(46):14176-82. PubMed ID: 11087366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.
    Sivakumaran V; Stanley BA; Tocchetti CG; Ballin JD; Caceres V; Zhou L; Keceli G; Rainer PP; Lee DI; Huke S; Ziolo MT; Kranias EG; Toscano JP; Wilson GM; O'Rourke B; Kass DA; Mahaney JE; Paolocci N
    Antioxid Redox Signal; 2013 Oct; 19(11):1185-97. PubMed ID: 23919584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level coexpression of the canine cardiac calcium pump and phospholamban in Sf21 insect cells.
    Autry JM; Jones LR
    Ann N Y Acad Sci; 1998 Sep; 853():92-102. PubMed ID: 10603939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.